Liver biopsy can sound intimidating, but for many people with liver disease it remains one of the best ways for doctors to see what is happening inside the liver. In a liver biopsy, a small piece of liver tissue is removed and examined under a microscope to check for inflammation, scarring, fat, infections, or tumors.

Doctors most often use two methods: percutaneous liver biopsy, which goes through the skin on the right side of the abdomen, and transjugular liver biopsy, which goes through a vein in the neck. Knowing how each approach works and what complications can occur helps patients understand why one method is chosen over another.

What Is a Liver Biopsy and Why Is It Done?

A liver biopsy is a procedure in which a thin needle removes a tiny sample of liver tissue for analysis.

Under the microscope, specialists can see how much scarring or cirrhosis is present, how much fat has built up, and whether there are signs of infection, autoimmune disease, or cancer. This information is often more precise than what blood tests or scans alone can provide.

Doctors may recommend a liver biopsy when liver enzymes are persistently abnormal, when chronic hepatitis B or C needs staging, or when conditions such as nonalcoholic fatty liver disease, autoimmune hepatitis, iron or copper overload, or certain genetic liver diseases are suspected.

A liver biopsy can also help clarify unclear imaging findings and guide decisions about medications and other treatments.

Percutaneous Liver Biopsy: Through the Skin

In a percutaneous liver biopsy, the doctor inserts a special biopsy needle through the skin, usually between the ribs on the right side, directly into the liver. Ultrasound is often used to guide the needle into a safe and useful area of liver tissue.

This method is common in people who do not have a high risk of bleeding and who do not have large amounts of fluid in the abdomen.

Before a percutaneous biopsy, patients are asked about medications, especially blood thinners and antiplatelet drugs, and blood tests are done to check clotting. Fasting for several hours is typical.

On the day of the procedure, the skin is cleaned and numbed. When the area is numb, the doctor passes the needle quickly into the liver to obtain one or several samples. The sampling step takes only seconds, though the overall visit is longer because of preparation and monitoring.

Most people experience mild soreness at the biopsy site for a day or two and sometimes brief pain that radiates to the right shoulder. Minor bruising or a small hematoma can also appear, according to Mayo Clinic.

More serious complications are much less common but include internal bleeding into the abdomen, injury to nearby organs, and infection. Very rarely, severe bleeding or other problems can be life-threatening.

After a percutaneous liver biopsy, patients are observed for several hours, and any increasing pain, dizziness, shortness of breath, or feeling faint after returning home should prompt urgent medical attention.

Transjugular Liver Biopsy: Through a Neck Vein

A transjugular liver biopsy takes an internal route. The doctor accesses the internal jugular vein in the neck, threads a thin catheter through the major veins into one of the hepatic veins inside the liver, and then advances a biopsy needle through the catheter to collect tissue samples.

Because the needle stays within the venous system and liver tissue, it does not puncture the outer liver capsule or enter the open abdominal cavity.

This approach is especially useful for people with a higher risk of bleeding, such as those with severe clotting problems, very low platelets, or large amounts of ascites. It is also often chosen in patients with severe obesity or those who have had a liver transplant.

Another advantage is that doctors can measure pressures inside the liver veins during the same procedure, which helps assess portal hypertension in advanced liver disease.

Preparation for a transjugular liver biopsy is similar, with medication review and blood tests. During the procedure, the neck is numbed, and a catheter is placed in the jugular vein under ultrasound and X‑ray guidance.

Read more

Patients usually receive sedation and may feel pressure in the neck or chest and brief discomfort in the right upper abdomen or shoulder. The procedure generally takes longer than a percutaneous biopsy but is still usually done as a day case or with a short hospital stay.

Transjugular biopsy complications differ somewhat from percutaneous biopsy complications. A small neck hematoma can occur at the access site. Because the catheter passes through the heart and large veins, brief heart rhythm changes may be seen but are usually well monitored.

Serious complications such as major bleeding, damage to veins, or injury to the lung are possible but uncommon. For high‑risk patients, the transjugular route tends to lower the chance of dangerous bleeding into the abdomen.

Percutaneous vs Transjugular: How Doctors Choose

When deciding between a percutaneous and a transjugular liver biopsy, doctors focus on safety and the likelihood of obtaining an adequate sample.

In patients with normal or only mildly impaired clotting and no large ascites, percutaneous biopsy is often preferred because it is straightforward and can provide slightly longer tissue cores. It remains the standard choice in many stable patients.

In contrast, when bleeding risk is high or when portal pressure measurements are needed, a transjugular liver biopsy is usually safer. Even if the tissue cores are sometimes smaller, they are usually adequate for diagnosis, and the reduced risk of serious complications is a key advantage, Cleveland Clinic.

The choice is tailored to each person based on clotting tests, platelet count, presence of ascites, body habitus, prior surgeries, and the specific clinical question. The aim is always to balance the value of the information gained from the liver biopsy with the lowest realistic risk of complications.

Liver Biopsy Choices

For individuals facing a liver biopsy, understanding the roles of percutaneous and transjugular techniques can make the process less overwhelming. Both approaches are designed to obtain a small but crucial sample of liver tissue that can reveal the cause and severity of liver disease and guide future treatment.

The decision between a percutaneous liver biopsy and a transjugular liver biopsy reflects a careful assessment of overall health, bleeding risk, and the need for additional measurements.

Knowing why a specific technique is recommended, what will happen during the procedure, and which complications to watch for helps patients feel more prepared and engaged in decisions about their liver care.

Frequently Asked Questions

1. Can a liver biopsy be repeated if results are unclear?

Yes. If the first liver biopsy sample is too small or does not fully explain the liver problem, doctors can repeat the biopsy later, often choosing the technique that is safest and most likely to give a better sample.

2. Are there non‑invasive alternatives to liver biopsy?

Yes. Blood tests and imaging techniques such as transient elastography (FibroScan) and MRI‑based methods can estimate liver scarring, but they do not always replace a liver biopsy when precise tissue diagnosis is needed.

3. Will a liver biopsy cure my liver disease?

No. A liver biopsy is a diagnostic test, not a treatment. It helps pinpoint the cause and severity of liver damage so the medical team can choose the most appropriate therapy.

4. Is one type of liver biopsy always less painful than the other?

Not always. Pain experience varies between individuals. Some find percutaneous biopsy more uncomfortable at the skin and liver site, while others notice more neck or shoulder discomfort after a transjugular biopsy, but both are usually manageable with simple pain relief.

Read more